By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Bolder BioTechnology, Inc. 

4056 Youngfield Street

Wheat Ridge  Colorado  80033  U.S.A.
Phone: 303-420-4420 Fax: 303-420-4426


SEARCH JOBS


Industry
Biotechnology

Segment
Pharmaceuticals





Company News
Bolder BioTechnology, Inc. Announces Publication of Data Demonstrating Utility of the Company's Long-Acting IL-11 Analog to Prevent Renal Ischemia Reperfusion Injury 8/30/2012 12:01:34 PM
Bolder BioTechnology, Inc. Announces $1.2 Million in Qualifying Therapeutic Discovery Project Grants 11/4/2010 6:53:13 AM
Bolder BioTechnology, Inc. Announces $600,000 Grant from National Institutes of Health (NIH) to Study Long-Acting IL-11 Analog in Treating Acute Radiation Syndrome 8/18/2010 11:34:54 AM
Bolder BioTechnology, Inc. Receives $1.2 Million National Institutes of Health (NIH) Grant to Continue Development of Long-Acting EPO Analog for Chronic Kidney Disease 9/17/2009 11:24:53 AM
Bolder BioTechnology, Inc. Receives $1.9 Million National Institutes of Health (NIH) Grant to Continue Development of Long-Acting Growth Hormone Product 12/17/2008 7:47:41 AM
Bolder BioTechnology, Inc. Receives $1.6 million National Institutes of Health (NIH) Grant to Continue Development of Multiple Sclerosis Drug 10/15/2008 11:28:41 AM
Bolder BioTechnology, Inc. Awarded National Institutes of Health (NIH) Phase I SBIR Grant To Develop Bioscavenger Protein For Detoxifying Nerve Agents10/19/2005 5:13:19 PM
Bolder BioTechnology, Inc. Receives U.S. Patent For Process Used To Manufacture Proprietary Second-Generation Protein Pharmaceuticals10/19/2005 5:12:36 PM
Bolder BioTechnology, Inc. Awarded National Institutes of Health (NIH) Grant To Develop Novel Arthritis Treatment10/19/2005 5:12:31 PM
Bolder BioTechnology, Inc. Receives National Institutes of Health (NIH) Grant For Preclinical Development Of Proprietary Erythropoiesis-Stimulating Protein10/19/2005 5:12:16 PM
12
//-->